Oxaloacetate reduces emotional symptoms in premenstrual syndrome (PMS): results of a placebo-controlled, cross-over clinical trial
Obstetrics & Gynecology Science · 15.03.2020 · 63 (2) · 195-204
DOI: 10.5468/ogs.2020.63.2.195 ↗Kurz gefasst
Fachartikel in der Zeitschrift Obstetrics & Gynecology Science, erschienen am 15.03.2020. Verfasst von Lisa Tully und 2 weiteren Autor:innen. Beteiligte Einrichtung: Nutritional Supplements Division, Energy Medicine Research Institute, Boulder, CO, USA. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Terra Biological LLC.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Nutritional Supplements Division, Energy Medicine Research Institute, Boulder, CO, USA.
- The Center for Health and Wellbeing, San Diego, CA, USA.
- Terra Biological LLC, San Diego, CA, USA.
ORCID-Profile: Alan Cash
Förderung
- Terra Biological LLC
Zitieren
APA
Tully, L., Humiston, J., & Cash, A. (2020). Oxaloacetate reduces emotional symptoms in premenstrual syndrome (PMS): results of a placebo-controlled, cross-over clinical trial. Obstetrics & Gynecology Science, 63(2), 195-204. https://doi.org/10.5468/ogs.2020.63.2.195
Vancouver
Tully L, Humiston J, Cash A. Oxaloacetate reduces emotional symptoms in premenstrual syndrome (PMS): results of a placebo-controlled, cross-over clinical trial. Obstetrics & Gynecology Science. 2020;63(2):195-204. doi:10.5468/ogs.2020.63.2.195
BibTeX
@article{Tully2020,
author = {Tully, Lisa and Humiston, John and Cash, Alan},
title = {Oxaloacetate reduces emotional symptoms in premenstrual syndrome (PMS): results of a placebo-controlled, cross-over clinical trial},
journal = {Obstetrics & Gynecology Science},
year = {2020},
volume = {63},
number = {2},
pages = {195--204},
doi = {10.5468/ogs.2020.63.2.195}
}
EUVIMED